Consumables, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, LC columns, LC/QQQ
IndustriesOther
ManufacturerThermo Fisher Scientific
Significance of the Topic
High-throughput bottom-up proteomics relies on stable, reproducible nano- and micro-flow LC-MS separations to deliver consistent peptide and protein quantitation across large sample cohorts. Achieving day-to-day and system-to-system robustness is critical for biomarker discovery, QA/QC processes, and cross-laboratory data integration.
Study Objectives and Overview
This study assessed the long-term chromatographic performance and reproducibility of the Thermo Scientific™ Vanquish™ Neo UHPLC system under both nanoLC and microLC configurations. Key aims included evaluating retention time and peak width stability over extended injection series and comparing proteome profiling consistency across multiple instrument setups.
Methodology and Instrumentation
Sample preparation
- BSA digest for UV-based stability tests: 1 pmol/µL, 90-min gradient.
- HeLa digest with PRTC standard: 200 ng/µL HeLa, 100 fmol/µL PRTC for nanoflow proteomics.
Instrument setup
- UHPLC: Vanquish Neo with thermostatted column compartment, SmartInject, double nanoViper fittings.
- Columns: EASY-Spray PepMap Neo, 75 µm×50 cm (nanoLC) and 1.0 mm ID (microLC).
- Mass spectrometers: Orbitrap Exploris 480 (DDA), Orbitrap Exploris 240 (HRAM), TSQ Altis QqQ (MRM).
- Detectors: UV detection via Chromeleon CDS.
Data processing
- Proteome Discoverer 2.5 with Sequest HT and INFERYS rescoring, FDR <1% at peptide and protein levels.
Main Results and Discussion
Long-term nanoLC-MS stability
- 1,600 BSA injections over 6 months: retention time deviation <0.3 min and peak FWHM remained consistent for eight monitored peptides.
- Column backpressure varied by <25 bar, indicating minimal clogging or degradation.
- 760 injections in ~7.5 days: 14.4 min cycle, pressure variation <3 bar, retention time RSD <0.5% for 12 PRTC peptides.
- Six Vanquish Neo systems with Exploris 240: HeLa digest profiling yielded ~33,000 peptides and 4,400 protein groups per run.
- Inter-system CV: 4.1% for peptide groups, 2.2% for protein groups; retention time RSD <0.2% across systems.
Benefits and Practical Applications
The demonstrated robustness enables:
- Reliable large-scale quantitative proteomics and biomarker discovery.
- Cross-laboratory standardization for multicenter studies.
- Reduced downtime and maintenance in routine QA/QC workflows.
Future Trends and Opportunities
Anticipated developments include:
- Integration of advanced AI-driven data processing for real-time quality monitoring.
- Expansion into multiplexed and higher-throughput designs without compromising chromatographic fidelity.
- Further miniaturization and standardized consumables to lower barriers for widespread adoption.
Conclusion
The Vanquish Neo UHPLC platform, combined with PepMap Neo columns and HRAM/QqQ detection, provides exceptional long-term stability and system-to-system reproducibility under demanding nano- and micro-flow conditions. These features support robust proteomics workflows and facilitate consistent data generation across laboratories.
Reference
- Bian Y., Zheng R., et al. Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS. Nat. Commun. 2020, 11, 157.
- Bian Y., Bayer F. P., et al. Robust Microflow LC-MS/MS for Proteome Analysis: 38000 Runs and Counting. Anal. Chem. 2021, 93(8), 3686–3690.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.